ProMIS Neurosciences Announces First Quarter 2020 Results

NEXT STORY
Capricor Announces Positive Top-Line Final Results from HOPE-2 Study in Patients with Duchenne Muscular Dystrophy Treated with Lead Candidate CAP-1002
PREV STORY
PDS Biotechnology Reports Financial Results for the First Quarter 2020 and Provides Business Update
Subscribe to PM360
Print Subscription

Experts on Call

Follow Us
Get in touch with PM360 Experts On Call

Ads

You May Also Like

Medeor Therapeutics Receives FDA Clearance of IND Application and Special Protocol Assessment for Pivotal Clinical Study of MDR-101

Personalized cellular immunotherapy designed to prevent transplant kidney rejection and eliminate the need for ...

author_avatar
NASDAQ Market News

Myriad and Pfizer Build Upon a Previously Announced Companion Diagnostic Agreement

Commercialization Plan Now in Place for BRACAnalysis CDx® As a Companion Diagnostic with Pfizer’s ...

author_avatar
NASDAQ Market News

Stemline Therapeutics Reports Fourth Quarter 2017 Financial Results

NEW YORK, March 16, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage ...

author_avatar
NASDAQ Market News